Google AI Enables Blood Pressure Monitoring via Smartwatches
New research suggests AI can detect hypertension without a traditional cuff.

An Innovative Approach to Health Monitoring
Google researchers have unveiled technology that allows smartwatches to diagnose arterial hypertension. This method removes the need for the traditional inflatable cuff typically required for blood pressure measurements. The system relies entirely on the pulse and motion sensors already present in smartwatches, making the feature accessible to a wider range of users.
Published in the scientific journal Nature, the study reveals that the artificial intelligence learned to recognise unique human heart rate patterns by analysing data from approximately 500,000 hours of recordings. The system evaluates data over several days to determine the probability of high blood pressure.
Research Results and Accuracy
The trial, conducted across five different research centres in the United States, involved 196 volunteers. The results demonstrated that the Google-developed model identifies hypertension with efficiency comparable to standard clinical methods. Specifically, the smartwatch system identified 65.8% of individuals with high blood pressure, whereas traditional office-based measurements showed an accuracy of 55.3%.
Google states that this technology is already integrated into the Google Health application as a feature for monitoring blood pressure trends. However, the company emphasises that the system is currently a research project and cannot replace an official diagnosis provided by a physician.
Why This Matters
High blood pressure is often referred to as a "silent killer," as more than half of those with hypertension are unaware of their condition. The primary goal of this new technology is to alert users to potential health issues in a timely manner and encourage them to consult a specialist for a thorough examination.
Although the technology is still being refined, its integration into everyday devices like smartwatches represents a significant step in the development of personalised medicine. In the future, such solutions could become an integral part of routine health monitoring, potentially reducing the risk of cardiovascular complications globally.